|
SNAP23 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.977200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.84499999999722E-05 |
| Normal-vs-Stage2 |
6.955200E-01 |
| Normal-vs-Stage3 |
1.915810E-01 |
| Normal-vs-Stage4 |
2.485200E-01 |
| Stage1-vs-Stage2 |
2.928100E-02 |
| Stage1-vs-Stage3 |
1.678240E-01 |
| Stage1-vs-Stage4 |
3.037200E-01 |
| Stage2-vs-Stage3 |
4.996600E-01 |
| Stage2-vs-Stage4 |
6.167200E-01 |
| Stage3-vs-Stage4 |
9.453200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.970430E-04 |
| Normal-vs-AfricanAmerican |
7.208000E-02 |
| Normal-vs-Asian |
8.929800E-01 |
| Caucasian-vs-AfricanAmerican |
1.080610E-01 |
| Caucasian-vs-Asian |
1.035430E-01 |
| AfricanAmerican-vs-Asian |
3.731800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.562700E-04 |
| Normal-vs-Female |
2.002600E-01 |
| Male-vs-Female |
2.655800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.121200E-03 |
| Normal-vs-Extreme_Weight |
6.40339999999906E-05 |
| Normal-vs-Obese |
1.219900E-02 |
| Normal-vs-Extreme_Obese |
5.582800E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.641400E-01 |
| Normal_Weight-vs-Obese |
8.268400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.386000E-01 |
| Extreme_Weight-vs-Obese |
1.631560E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.954000E-01 |
| Obese-vs-Extreme_Obese |
3.903800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.178800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.533710E-02 |
| Normal-vs-Age(61-80Yrs) |
1.356770E-04 |
| Normal-vs-Age(81-100Yrs) |
2.738000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.976000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.949900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.921600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.017700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.039600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.723000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.169500E-04 |
| Normal-VS-Type2 PRCC |
1.980180E-02 |
| Normal-VS-KIRP CIMP |
7.148200E-01 |
| Normal-VS-Unclassified PRCC |
3.119800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.357800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.099590E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.513500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.654960E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.894800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.979800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.898700E-03 |
| Normal-vs-N1 |
4.309800E-01 |
| Normal-vs-N2 |
2.868000E-01 |
| N0-vs-N1 |
2.248600E-01 |
| N0-vs-N2 |
4.868600E-01 |
| N1-vs-N2 |
3.355800E-01 |
|
|
